ArticleFrontiers in physiology2025
A comparative study on L-thyroxine treatment and sesame oil supplementation in experimentally induced hypothyroidism in rats.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Natural antioxidants have gained increasing attention in medical and nutritional research. Sesame oil, a supplement widely recognized for its anti-inflammatory and antioxidant properties, remains underexplored with respect to its potential role in hypothyroidism management. Levothyroxine is currently the mainstay of therapy for hypothyroidism. Based on this, we aimed to demonstrate the effects of different treatments on the systemic parameters, including the liver and heart, of hypothyroid rats and to elucidate the underlying mechanisms. Methodology: Adult female Wistar rats (n = 66) were randomly allocated into control, sesame oil-treated euthyroid, propylthiouracil-induced hypothyroid, L-thyroxine-treated hypothyroid, sesame oil-treated hypothyroid, and combined treated hypothyroid groups. After 8 weeks, arterial blood pressure values were measured using a noninvasive rat tail sphygmomanometer. On the day of sacrifice and after overnight fasting, rats were anesthetized with pentobarbitone, and electrocardiograms were recorded. Separated plasma samples were used to measure the thyroid hormone levels, cardiac and liver enzymes, lipid profile, oxidative stress markers, and interleukin-6. Hepatic low-density lipoprotein receptor concentration and hepatic stearoyl-CoA desaturase 1 gene expression were determined, in addition to histopathological studies of heart and liver tissues. Results: Primary hypothyroidism was evident in the hypothyroid group, whereas all treated groups were euthyroid. Compared to the control group, the hypothyroid group exhibited systolic hypotension, diastolic hypertension, arrhythmia, higher cardiac enzymes, dyslipidemia, impaired liver functions, upregulated hepatic stearoyl-CoA desaturase 1 expression, lower hepatic low-density lipoprotein receptor concentration, cardiomyopathy, and focal hepatic fibrosis. Both L-thyroxine and sesame oil showed cardioprotective and hepatoprotective effects, whereas sesame oil exhibited greater lipolytic effects by enhancing low-density lipoprotein receptor concentration; both caused downregulated hepatic stearoyl-CoA desaturase 1 gene expression. Hypothyroid-induced oxidative stress was limited in all treated groups, whereas sesame oil had additional anti-inflammatory effects. Synergistic lipolytic effects and better control of diastolic blood pressure were observed in the hypothyroid group treated with the combination. Conclusion: Sesame oil has the potential to be utilized as an adjuvant therapy with L-thyroxine to counteract the cardiac and hepatic alterations induced by hypothyroidism. This is supported by its antioxidant, anti-inflammatory, and antisteatotic characteristics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.